VJ
Vishal Jaiswal
About Vishal Jaiswal
Data last updated:
Vishal Jaiswal has 5 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Jaiswal Pharmaceuticals Private Limited and Prathamax Nova Estates Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Jaiswal Pharmaceuticals Private Limited at ₹50.75 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Oct 2020 | 2020 | ₹50.75 Cr (FY 2024) | Active | |
| Designated Partner | 22 May 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishal Jaiswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishal Jaiswal
Vishal Jaiswal has 5 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Jaiswal Pharmaceuticals Private Limited and Prathamax Nova Estates Llp. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Jaiswal Pharmaceuticals Private Limited at ₹50.75 Cr (FY 2024).
Vishal Jaiswal is associated with 2 companies as Director and Designated Partner, including Jaiswal Pharmaceuticals Private Limited (₹50.75 Cr), Prathamax Nova Estates Llp.
Vishal Jaiswal has expertise in General Business.
Vishal Jaiswal has 5 years in corporate governance.
By reported revenue, the largest current company of Vishal Jaiswal is Jaiswal Pharmaceuticals Private Limited, with revenue of ₹50.75 Cr (FY 2024).
Vishal Jaiswal currently holds positions at 2 companies: Jaiswal Pharmaceuticals Private Limited (₹50.75 Cr), Prathamax Nova Estates Llp.